(Q41641774)

6 October 2017

1 reference

title

Therapy of systemic vasculitis (English)

1 reference

6 October 2017

Calabrese LH

1

1 reference

6 October 2017

publication date

1 November 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

15

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

973-991

1 reference

Mixed cryoglobulinemia secondary to hepatitis C virus infection

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Molecular mechanism of methotrexate action in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Cyclophosphamide toxicity. Characterising and avoiding the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Intravenous immunoglobulin in rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Approaches to specific immunotherapy for systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Biologic agents for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Current therapies for systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

Cyclosporine, FK-506, rapamycin, and other immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970359-5

7 January 2021

10.1016/S0733-8619(05)70359-5

Identifiers

DOI

1 reference

6 October 2017

1 reference